Bio
Martin R. Schiller received a B.S. from Hofstra University and a Ph.D. from Utah State University, both in Biochemistry. After 3 postdoctoral fellowships, he was appointed to the faculty at The Johns Hopkins University and later, at the University of Connecticut working on peptide prohormones. He is now a Prabhu-endowed professor at the University of Nevada, Las Vegas and the founding director of the Nevada Institute of Personalized Medicine established in 2015. His research focuses on functional genomics, bioinformatics and discovery of Biologics. His laboratory has produced a suite of bioinformatic tools. He has published 90 papers, supported by 27 research grants (~$31M) from the NIH. His research has spawned one of the first Las Vegas biotech startup companies, Heligenics. Heligenics produces mutational effect on gene activity maps to engineer new companion diagnostics and biologic drugs. Heligenics’s GigaAssay developed in his academic lab, is the first technology to enable High Content Screening for Biologic Drugs and has produced several Interferon assets in development.